Photo from wikipedia
Key Points • Patients who underwent core needle biopsy are more likely to have poor-risk disease features and inadequate tissue for molecular analyses.• Increasing tissue requirements of biomarker-driven trials may… Click to show full abstract
Key Points • Patients who underwent core needle biopsy are more likely to have poor-risk disease features and inadequate tissue for molecular analyses.• Increasing tissue requirements of biomarker-driven trials may exclude patients with high-risk DLBCL who need novel agents.
Keywords:
increasing tissue;
trials may;
risk;
risk disease;
tissue requirements;
tissue
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!